OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Applications of covalent chemistry in targeted protein degradation
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 44
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 44
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease
Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6495-6507
Open Access | Times Cited: 22
Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6495-6507
Open Access | Times Cited: 22
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 31
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 31
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 29
Barmak Mostofian, Holli‐Joi Martin, Asghar M. Razavi, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 17, pp. 5408-5432
Open Access | Times Cited: 29
Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency
Charu Chaudhry
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6239-6250
Closed Access | Times Cited: 26
Charu Chaudhry
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6239-6250
Closed Access | Times Cited: 26
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 25
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 25
Template-assisted covalent modification underlies activity of covalent molecular glues
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 15
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 15
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
High‐Throughput Miniaturized Synthesis of PROTAC‐Like Molecules
Ye Tian, Maximilian Seifermann, Liana Bauer, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 6
Ye Tian, Maximilian Seifermann, Liana Bauer, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 6
Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemia
Yunkai Shi, Minmin Liu, Mengna Li, et al.
Chemical Science (2024) Vol. 15, Iss. 13, pp. 5027-5035
Open Access | Times Cited: 6
Yunkai Shi, Minmin Liu, Mengna Li, et al.
Chemical Science (2024) Vol. 15, Iss. 13, pp. 5027-5035
Open Access | Times Cited: 6
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 4
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 4
Development of a RIPK1 degrader to enhance antitumor immunity
Xin Yu, Dong Lu, Xiaoli Qi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Xin Yu, Dong Lu, Xiaoli Qi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis
Shang Li, Liangliang Ma, Xinxin Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15353-15372
Closed Access | Times Cited: 2
Shang Li, Liangliang Ma, Xinxin Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15353-15372
Closed Access | Times Cited: 2
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Targeted protein degradation bypassing cereblon and von Hippel-Lindau
Wenchao Lu
The Innovation (2023) Vol. 4, Iss. 3, pp. 100422-100422
Open Access | Times Cited: 5
Wenchao Lu
The Innovation (2023) Vol. 4, Iss. 3, pp. 100422-100422
Open Access | Times Cited: 5
Recent advances of AIE ‐active materials for orthotopic tumor phototheranostics
Yan Sun, Yonghong Tan, Dingyuan Yan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 5
Yan Sun, Yonghong Tan, Dingyuan Yan, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 5
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in fda-approved drugs
Jan Felix Scholtes, Cristóbal Alhambra, Philip A. Carpino
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 843-861
Closed Access | Times Cited: 1
Jan Felix Scholtes, Cristóbal Alhambra, Philip A. Carpino
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 843-861
Closed Access | Times Cited: 1
A prospective therapeutic strategy: GPX4-targeted ferroptosis mediators
Jia-Yu Qian, Chao-Yuan Lou, Yili Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117015-117015
Closed Access | Times Cited: 1
Jia-Yu Qian, Chao-Yuan Lou, Yili Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117015-117015
Closed Access | Times Cited: 1
A Self-Assembled Nano-Molecular Glue (Nano-mGlu) Enables GSH/H2O2-Triggered Targeted Protein Degradation in Cancer Therapy
Jie Sun, Mingxi Gu, Liang Peng, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 1
Jie Sun, Mingxi Gu, Liang Peng, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 1
Innovative design and potential applications of covalent strategy in drug discovery
Tianxi Tang, Jiaxiang Luo, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117202-117202
Closed Access | Times Cited: 1
Tianxi Tang, Jiaxiang Luo, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117202-117202
Closed Access | Times Cited: 1
Setting sail: Maneuvering SHP2 activity and its effects in cancer
Colin L. Welsh, Sarah Allen, Lalima K. Madan
Advances in cancer research (2023), pp. 17-60
Open Access | Times Cited: 3
Colin L. Welsh, Sarah Allen, Lalima K. Madan
Advances in cancer research (2023), pp. 17-60
Open Access | Times Cited: 3
Profiling nuclear cysteine ligandability and effects on nuclear localization using proximity labeling-coupled chemoproteomics
Qianni Peng, Eranthie Weerapana
Cell chemical biology (2023) Vol. 31, Iss. 3, pp. 550-564.e9
Closed Access | Times Cited: 3
Qianni Peng, Eranthie Weerapana
Cell chemical biology (2023) Vol. 31, Iss. 3, pp. 550-564.e9
Closed Access | Times Cited: 3
